Prometheus Laboratories Inc. - Citizen Petition
This Other document was issued by the Food and Drug Administration (FDA)
For related information, Open Docket Folder
See attached file(s)
No documents available.
Exhibit 2 KD Bardhan et al A Double Blind Randomized Placebo Controlled Dose Ranging Study to Evacuate the Efficacy of Alosetron...
Exhibit 3 K Holten et al Diagnosing the Patient with Abdominal Pain and Altered Bowel Habits is it Irritable Bowel Syndrome
Exhibit 4 NIH Public Access D Drossman et al International Survey of Patients With IBS Symptom Features and Their Severity Health...
Exhibit 5 Pare et al Health Related Quality of Life Work Productivity and Health Care Resource Utilization of Subjects With...
Exhibit 6 Lotronex Welcome to Prescribing Program for Lotronex PPL
Exhibit 7 FDA Response to Citizen Petition Filed by Reckitt Benkiser Pharmaceuticals Inc
Exhibit 8 Citizen Petitions Filed by the following Roxane Laboratories Inc Dr Reddy Laboratories and Jazz Pharmaceuticals
Exhibit 9 Prepared Statement of the Federal Trade Commission Before the Subcommittee on Commerce
Exhibit 10 Brief for the Federal Trade Commission Brief as Amicus Curiae In re Effexor XR Antitrust Litigation Case
Exhibit 11 FDA Response to Reckitt Benckiser Pharmaceuticals Inc
Exhibit 12 FTC In the Matter of Bristol Myers Squibb Co Complaint
| || |
Show More Details
Date Posted: May 28, 2013
Country: United States
Category: Private Industry - C0003
This document is contained in
Related Dockets: None
Related RINs: None
* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.